Toronto Dominion Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303M Sell
329,370
-55,341
-14% -$56.1M 0.43% 43
2025
Q4
$413M Buy
384,711
+89,188
+30% +$85.3M 0.61% 28
2025
Q3
$225M Sell
295,523
-29,081
-9% -$21.6M 0.35% 53
2025
Q2
$253M Buy
324,604
+22,841
+8% +$17.7M 0.42% 41
2025
Q1
$249M Buy
301,763
+112,469
+59% +$93.6M 0.49% 37
2024
Q4
$146M Sell
189,294
-73,611
-28% -$61M 0.23% 62
2024
Q3
$233M Sell
262,905
-115,160
-30% -$104M 0.41% 37
2024
Q2
$342M Sell
378,065
-14,024
-4% -$11.2M 0.55% 28
2024
Q1
$305M Sell
392,089
-86,036
-18% -$61.2M 0.48% 29
2023
Q4
$279M Buy
478,125
+36,390
+8% +$21.2M 0.4% 43
2023
Q3
$237M Sell
441,735
-12,538
-3% -$6.46M 0.39% 42
2023
Q2
$213M Buy
454,273
+12,172
+3% +$5.1M 0.32% 53
2023
Q1
$152M Sell
442,101
-123,836
-22% -$41.8M 0.25% 70
2022
Q4
$207M Buy
565,937
+191,545
+51% +$67.9M 0.31% 55
2022
Q3
$121M Sell
374,392
-60,257
-14% -$19.1M 0.22% 69
2022
Q2
$141M Sell
434,649
-64,374
-13% -$19.3M 0.26% 62
2022
Q1
$143M Sell
499,023
-156,443
-24% -$40.3M 0.22% 70
2021
Q4
$181M Buy
655,466
+48,807
+8% +$12.4M 0.24% 67
2021
Q3
$140M Buy
606,659
+219,373
+57% +$54.1M 0.22% 69
2021
Q2
$88.9M Sell
387,286
-46,025
-11% -$9.25M 0.14% 105
2021
Q1
$81M Sell
433,311
-120,204
-22% -$23.5M 0.14% 102
2020
Q4
$93.5M Buy
553,515
+58,220
+12% +$8.69M 0.17% 91
2020
Q3
$73.3M Sell
495,295
-91,461
-16% -$14.2M 0.18% 94
2020
Q2
$96.3M Sell
586,756
-67,161
-10% -$10.3M 0.24% 76
2020
Q1
$90.7M Sell
653,917
-171,257
-21% -$23.5M 0.28% 69
2019
Q4
$108M Buy
825,174
+156,671
+23% +$18.2M 0.18% 90
2019
Q3
$74.8M Sell
668,503
-625,073
-48% -$69.6M 0.16% 107
2019
Q2
$71.7M Buy
1,293,576
+653,395
+102% +$76.9M 0.15% 100
2019
Q1
$83M Buy
640,181
+51,256
+9% +$6.23M 0.13% 94
2018
Q4
$68.1M Sell
588,925
-73,354
-11% -$8.19M 0.12% 90
2018
Q3
$71.1M Buy
662,279
+16,593
+3% +$1.66M 0.13% 104
2018
Q2
$55.1M Buy
645,686
+95,323
+17% +$7.83M 0.11% 126
2018
Q1
$42.6M Buy
550,363
+101,552
+23% +$8.18M 0.09% 120
2017
Q4
$37.9M Buy
448,811
+50,113
+13% +$4.26M 0.11% 114
2017
Q3
$34.1M Buy
398,698
+39,260
+11% +$3.22M 0.11% 113
2017
Q2
$29.6M Buy
359,438
+66,936
+23% +$5.46M 0.09% 129
2017
Q1
$24.6M Buy
292,502
+93,663
+47% +$7.5M 0.07% 146
2016
Q4
$14.6M Buy
198,839
+144,467
+266% +$10.8M 0.04% 155
2016
Q3
$4.37M Buy
54,372
+23,388
+75% +$1.87M 0.01% 221
2016
Q2
$2.45M Sell
30,984
-2,896
-9% -$218K 0.01% 201
2016
Q1
$2.43M Sell
33,880
-25,478
-43% -$1.93M 0.02% 182
2015
Q4
$5.01M Sell
59,358
-1,434
-2% -$119K 0.03% 157
2015
Q3
$5.1M Buy
60,792
+3,942
+7% +$333K 0.03% 157
2015
Q2
$4.75M Buy
56,850
+451
+0.8% +$34.4K 0.02% 188
2015
Q1
$4.1M Sell
56,399
-15,184
-21% -$1.08M 0.02% 197
2014
Q4
$4.93M Buy
71,583
+23,142
+48% +$1.56M 0.02% 189
2014
Q3
$3.33M Sell
48,441
-1,226
-2% -$77.6K 0.01% 214
2014
Q2
$3.08M Buy
49,667
+26,799
+117% +$1.6M 0.01% 233
2014
Q1
$1.36M Sell
22,868
-92
-0.4% -$5.13K ﹤0.01% 319
2013
Q4
$1.17M Buy
22,960
+9,164
+66% +$459K ﹤0.01% 322
2013
Q3
$693K Sell
13,796
-810
-6% -$42.4K ﹤0.01% 354
2013
Q2
$720K Buy
+14,606
New +$795K ﹤0.01% 338

Other funds holding LLY

Toronto Dominion Bank's LLY Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $56.1M and leaving 329,370 shares worth $303M. The position accounts for 0.43% of the portfolio, ranked #43.

Toronto Dominion Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $413M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Toronto Dominion Bank held 329,370 shares of Eli Lilly worth $303M as of Q1 2026.
  • Toronto Dominion Bank sold 55,341 Eli Lilly shares in Q1 2026, an estimated $56.1M.
  • Eli Lilly made up 0.43% of Toronto Dominion Bank's portfolio in Q1 2026, its #43 holding.
  • Toronto Dominion Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Eli Lilly position peaked at $413M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.